Intensive Lifestyle Interventions to Overweight and Obese Patients in Primary Care
NCT ID: NCT06321809
Last Updated: 2025-02-04
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
165 participants
OBSERVATIONAL
2022-01-25
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* effect on anthropometric measurements
* effect on lipid profile
* effect on weight-related quality of life
* observe the differences between interventions The study participants were stratified into three groups: intervention, control-1, and control-2.
* Intervention group: They were given a calorie-restricted diet and exercise plan by a dietician or physiotherapist at their first visit, and were followed up by telephone calls at weeks 2, 4, 6, 8 and 10 over 12 weeks.
* Control-1 group: During the initial medical interview, the participants were given a calorie-restricted diet programme by a dietician and an exercise programme by a physiotherapist; they were followed up over 12 weeks with telephone calls at week 4.
* Control-2 group: The participants were not provided with any programme, and the importance of weight loss was emphasised by the family physicians. Dietary and physical activity advice was given according to the recommendations in the Turkish Endocrine and Metabolism Association 2019 Obesity Diagnosis and Treatment Guide, and was followed up with phone calls at weeks 2, 4, 6, 8 and 10 over a 12-weeks.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise Supervision Duration and Adherence in Obese Women
NCT07152028
The Effect of Telephone and Video Counseling on Weight Loss and Quality of Life
NCT05276544
Interventions for Lifestyle Changes to Promote Weight Reduction, a Randomized Controlled Trial in Primary Health Care
NCT01606917
Lifestyle Intervention on Patients With Overweight or Obesity
NCT06829862
The Effects of a Weight Management Program on Body Weight and Quality of Life
NCT02219763
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
They were given a calorie-restricted diet and exercise plan by a dietician or physiotherapist at their first visit, and were followed up by telephone calls at weeks 2, 4, 6, 8 and 10 over 12 weeks.
intensive lifestyle
INTENSIVE LIFESTYLE INTERVENTIONS
Control-1 group
During the initial medical interview, the participants were given a calorie-restricted diet programme by a dietician and an exercise programme by a physiotherapist; they were followed up over 12 weeks with telephone calls at week 4.
intensive lifestyle
INTENSIVE LIFESTYLE INTERVENTIONS
Control-2 group
The participants were not provided with any programme, and the importance of weight loss was emphasised by the family physicians. Dietary and physical activity advice was given according to the recommendations in the Turkish Endocrine and Metabolism Association 2019 Obesity Diagnosis and Treatment Guide, and was followed up with phone calls at weeks 2, 4, 6, 8 and 10 over a 12-weeks.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intensive lifestyle
INTENSIVE LIFESTYLE INTERVENTIONS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Secondary obesity (hypothyroidism, Cushing\'s disease, etc.)
* Chronic disease (cardiovascular diseases, pulmonary diseases, presence of diabetes mellitus, liver diseases, renal diseases)
* Having hyperlipidaemia under treatment
* Cancer
* Pregnancy or breastfeeding
* Psychiatric disorder
* Orthopaedic or neurological disease that may prevent walking
* Are currently taking weight loss medication or enrolled in another weight loss program
* Having previously undergone obesity surgery or having surgery planned during the study period
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Duygu Ayhan Baser
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Duygu Ayhan Baser
Assoc Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Duygu Ayhan Baser, Assoc. Prof.
Role: STUDY_DIRECTOR
Hacettepe University
Dilara Canbay Ozdemir, M.D.
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
İzzet Fidanci, Assoc. Prof.
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
Arzu Demircioglu Karagoz
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
Merve Ozdemir
Role: PRINCIPAL_INVESTIGATOR
Afyonkarahisar Health Sciences University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacettepe University
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUTF-FM-DABDCO-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.